Adults increasingly using ADHD medications

Adults increasingly using ADHD medications


Express Scripts notes that these prescriptions may not, in fact, be for ADHD.

NYT picks apart ADHD

The Gray Lady surveys the landscape of attention deficit disorder marketing.

ADHD rise spurs diagnostics firms

ADHD rise spurs diagnostics firms


Research suggests ADHD is becoming a regular fixture in adolescence. At the same time, publishers and startups have developed increasingly complex tools to separate patients from abusers.

Rising ADHD prescriptions draw scrutiny

The uptick is being linked to looser DSM guidelines.

Business briefs: CDC, Facebook, Shire

CDC finds that non-Medicare adults make up the majority of preventable heart attack and stroke cases; a Facebook study shows groups can influence HIV screening; and a Shire ADHD drug gets a "no" from Germany

Business Briefs: Kantar Media, Janssen, Eli Lilly, Boehringer Ingelheim, Sanofi, Aveo

Healthcare critics continue to spend on anti-ACA ads; Janssen plunges into the microbiome; Lilly gets adult ADHD indication in UK; Sanofi pulls two drugs; and Aveo lays off 140.

Business briefs: Shire, AthenaHealth, GSK, Novartis

Shire expands its pipeline yet again, AthenaHealth stretches its HCP-patient reach, FDA delays GSK's bird-flu vaccine, Novartis wins approval for cystic fibrosis inhaler

Business briefs: Gilead, Shire, The Medicines Co., HHS

HHS wants input for its TXT4Tots childhood advice program, Gilead releases some Hep. C clinical trial data, and Shire settles with the DOJ over disputed marketing practices.

Shire launches ADHD tech challenge


Taking a page from Sanofi, Shire is preparing to launch a developer challenge "to create technology driven solutions that aid individuals with ADHD during the transition from adolescence into adulthood."

Reimagining healthcare? We want to hear about it.
Submit nominations here for MM&M's first-ever list of the Top 40 Healthcare Transformers

Email Newsletters